Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro
- 1 May 2002
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 102 (2) , 188-194
- https://doi.org/10.1016/s0301-2115(01)00582-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cellsin vitroNutrition and Cancer, 1997
- Molecular effects of genistein on estrogen receptor mediated pathwaysCarcinogenesis: Integrative Cancer Research, 1996
- Inhibition of tumor Promoter‐induced hydrogen peroxide formationin vitroandin vivoby genisteinNutrition and Cancer, 1993
- Flavones. 3. Synthesis, biological activities, and conformational analysis of isoflavone derivatives and related compoundsJournal of Medicinal Chemistry, 1992
- Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance geneBiochemical and Biophysical Research Communications, 1991
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- Transformation of Human Breast Epithelial Cells by c‐Ha‐ras OncogeneMolecular Carcinogenesis, 1991
- Antiproliferative Activity of Mammalian Lignan Derivatives Against the Human Breast Carcinoma Cell Line, ZR-75-1Cancer Investigation, 1990
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985